Activity Overview
Please read the following information about this continuing pharmacy education (CPE) activity before accessing the presentations using links located at the bottom of this page.
Accreditation for Pharmacists
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity provides 2 hours (0.2 CEUs) of continuing pharmacy education credit (ACPE Activity #204-000-10-482-H05P).
Methods and Format
This is an online activity consisting of audio and slides, a post-test, and an activity evaluation tool. Participants should claim continuing pharmacy education credit for this internet-based educational activity only if they have not claimed credit for the live activity. Participants must view the presentation in its entirety, take the activity post-test, and complete the course evaluation to receive continuing pharmacy education credit. A minimum score of 70% is required on the test for credit to be awarded, and participants may print their official statements of continuing pharmacy education credit immediately. The estimated time to complete this activity is 2 hours. This activity is provided free of charge.
Target Audience
This continuing pharmacy education activity is beneficial for pharmacists including clinicians, managers, and educators who are interested in learning more about ensuring the safety of intravenous medication administration in high risk patients and in transitions of care.
Activity Content
Ensuring the safety of providing intravenous (i.v.) medications to patients is critical, especially in high risk patient populations and in transitioning care to and from the hospital setting. This symposium will provide pharmacists with practical methods for minimizing potential i.v. medication errors in high risk patient populations such as pediatrics and critical care, and in patients receiving infusions for the treatment of chronic diseases. The most common causes of medication errors in these high risk populations and vulnerabilities related to transitions of care will be examined. Strategies for enhanced safety will be discussed.
Learning Objectives
After participating in this knowledge-based CPE activity, participants should be able to
- Summarize national efforts to improve i.v. medication safety.
- Describe common i.v. medication errors impacting high risk populations.
- Identify strategies to minimize risk for i.v. medication errors in high risk populations and in patients transitioned to and from the hospital setting.
- Develop a risk assessment process to evaluate i.v. medication safety.
Faculty
Rita Shane, Pharm.D., FASHP, FSCHP, ChairDirector, Pharmacy Services
Cedars-Sinai Medical Center
Los Angeles, California
Rita Shane, Pharm.D., FASHP, FCSHP, is Director of Pharmacy Services at Cedars-Sinai Medical Center, a 950-bed acute- and tertiary-care, teaching institution in Los Angeles, CA, and Assistant Dean, Clinical Pharmacy Services at the University of California, San Francisco (UCSF), School of Pharmacy. She is responsible for more than 300 staff members. Dr. Shane’s goal is to ensure that wherever patients need care, there is a demand for pharmacists to ensure optimal management of medications.
Over the years, Dr. Shane has been recognized for her passion for the profession. She is the recipient of the 2007 California Society of Health-System Pharmacists (CSHP) Pharmacist of the Year Award and the 2007 Distinguished Service Award from the ASHP Section of Pharmacy Practice Managers. Dr. Shane was the 2005 recipient of the ASHP Distinguished Leadership Award and the 1995 recipient of the John Webb Visiting Professorship in Hospital Pharmacy for management excellence.
Dr. Shane is a co-investigator in two research studies in collaboration with the UCSF School of Pharmacy and approved by the California State Board of Pharmacy to demonstrate the safety and importance of allowing technicians to check technician-filled medication cassettes in hospitals. She also worked collaboratively with CSHP to author language in support of this regulatory change, which was approved by the State of California effective in January 2007. Dr. Shane was co-investigator of a 2000 National Patient Safety Foundation Research Award to study the impact of dedicated medication nurses on the rate of medication administration errors, a randomized, controlled trial the results of which were subsequently published in the Archives of Internal Medicine.
Dr. Shane recently served as the U.S. facilitator at the Global Conference on the Future of Hospital Pharmacy held during the 68th Congress of the International Pharmaceutical Federation and was responsible for reviewing the international literature on the subject of medication administration. She also is one of the investigators in a multicenter study of medications errors recovered by emergency department pharmacists which was published in the Annals of Emergency Medicine. Throughout her career, Dr. Shane has participated on committees and task forces at the state and national level; she recently was a member of the American Hospital Association Committee on Health Professions and the National Quality Forum Patient Safety Advisory Committee. She is currently the ASHP representative to The Joint Commission Hospital Professional Technical Committee. She has presented at local, state, national, and international meetings and has published a number of papers in the pharmacy literature including one of the background papers for the recent ASHP Pharmacy Practice Model Summit.
Judith Jacobi, Pharm.D., FCCM, FCCP, BCPSPresident, Society of Critical Care Medicine and
Critical Care Pharmacist
Methodist Hospital / Clarian Health
Indianapolis, Indiana
Judith Jacobi, Pharm.D., FCCM, FCCP, BCPS, DNAP, is a Critical Care Pharmacy Specialist for the Adult Critical Care and Neuro-Critical care Units at Methodist Hospital, a division of Clarian Health Partners in Indianapolis, Indiana. She is the current President of the Society of Critical Care Medicine (SCCM), and she was a founding member of the Clinical Pharmacy and Pharmacology Section in 1989.
Dr. Jacobi trained as a pharmacist at Purdue University and received her Doctor of Pharmacy from the University of Minnesota, and she was one of the first critical care pharmacy residents trained at The Ohio State University. She became a Fellow of the American College of Critical Care Medicine (FCCM) in 1992, and she is a Board Certified Pharmacotherapy Specialist (BCPS).
Dr. Jacobi is Program Director of a Critical Care Pharmacy Residency and has trained many residents, along with numerous Doctor of Pharmacy students as Affiliate Assistant Faculty for Purdue University, Butler University and the National University of Singapore.
Elizabeth Farrington, Pharm.D., FCCM, FCCP, BCPSClinical Assistant Professor
University of North Carolina College of Pharmacy
Pharmacist III - Pediatrics
New Hanover Regional Medical Center
Wilmington, North Carolina
Elizabeth Farrington, Pharm.D., FCCM, FCCP, BCPS, is a Pharmacist III in Pediatrics at the New Hanover Regional Medical Center in Wilmington, North Carolina and a Clinical Assistant Professor at the University of North Carolina (UNC) Eshelman School of Pharmacy, Chapel Hill.
For the past twenty years, Dr. Farrington’s primary area of practice has been the Pediatric Intensive Care Unit (PICU). She has worked closely with nursing to implement standard concentrations and smart pump technology in the pediatric hospital.
Dr. Farrington earned her Bachelor of Science in Pharmacy at the University of North Carolina in 1983 and her Doctor of Pharmacy degree from the University of Kentucky in 1985. She completed a two-year clinical pharmacy residency which included one year in pediatrics at the University of Kentucky. She also completed a Pediatric Research Fellowship at the University of Iowa in 1989. Dr. Farrington previously directed a Pediatric Pharmacotherapy Residency and has trained over fourteen residents.
Disclosure Statement
In accordance with the Accreditation Council for Continuing Medical Education's Standards for Commercial Support and the Accreditation Council for Pharmacy Education's Guidelines for Standards for Commercial Support, ASHP Advantage requires that all individuals who have control in planning or presenting educational content disclose all relevant financial relationships with any commercial interest. This includes faculty, teachers, authors, activity directors, and members of planning committees. An individual has a relevant financial relationship if the individual or his or her spouse/partner has a financial relationship (e.g., employee, consultant, research grant recipient, speaker's bureau, or stockholder) in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the educational activity content over which the individual has control.The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on presentations.
All faculty and planners for ASHP Advantage educational activities are qualified and selected by ASHP Advantage and required to disclose any relevant financial relationships with commercial interests. ASHP Advantage identifies and resolves conflicts of interest prior to an individual's participation in development of content for an educational activity.
Rita Shane, Pharm.D., FASHP, FCSHP
Dr. Shane declares that she has no relationships pertinent to this activity.
Judith Jacobi, Pharm.D., FCCM, FCCP, BCPS
Dr. Jacobi declares that she has no relationships pertinent to this activity.
Elizabeth Farrington, Pharm.D., FCCM, FCCP, BCPS
Dr. Farrington declares that she has no relationships pertinent to this activity.
Ron DeChant, M.S., B.S.Pharm.
Mr. DeChant declares that he has no relationships pertinent to this activity.
This activity is supported by an educational grant from Hospira, Inc.
Launch Presentation*
(10 minutes)
Rita Shane, Pharm.D., FASHP, FCSHP, Chair
Intravenous Medications in Pediatric Patients: Safety First
(35 minutes)
Elizabeth Farrington, Pharm.D., FCCM, FCCP, BCPS
Critical Care = Critical Therapy: Safe Use of I.V. Therapies
(30 minutes)
Judith Jacobi, Pharm.D., FCCM, FCCP, BCPS
Transitions of Care: Safety Considerations for Patients Receiving Infusions to Treat Chronic Diseases
(30 minutes)
Rita Shane, Pharm.D., FASHP, FCSHP
Questions and Answers
(15 minutes)
All Faculty
*Allow additional time to complete the post-test and evaluation.
Download Post-Test
Print the post-test for your reference. Please note that to be eligible for continuing pharmacy education credit, you must go to the ASHP Learning Center and complete the test online.
Planned and coordinated by ASHP Advantage.
